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IL-27, a novel IL-12 family cytokine, is a het-
erodimeric molecule composed of Epstein-Barr 
virus–induced gene 3 (EBI3), an IL-12 p40-
related protein, and p28, an IL-12 p35-related 
polypeptide (1). IL-27 is produced early by ac-
tivated antigen-presenting cells in response to 
microbial infection. It is able to induce clonal 
proliferation of naive but not memory CD4+ 
T cells and synergizes with IL-12 in IFN-γ 
production by naive CD4+ T cells (1). IL-27 
plays an important role in autoimmune disease 
and host defense against infection. IL-27 re-
ceptor/WSX-1 knockout mice show increased 
susceptibility to intracellular pathogens such as 
Leishmania major (2) and Listeria momocytogenes (3) 
because of impaired IFN-γ production from 
CD4+ T cells. IL-27 p28 (abbreviated as p28 
hence forth) is highly expressed in infl  amma-
tory bowel diseases (4, 5) and experimental 
autoimmune encephalomyelitis (6). Neutral-
izing the p28 subunit suppressed the ongoing 
adjuvant-induced arthritis (7). Recent studies, 
however, have shown that IL-27/WSX-1 sig-
naling also negatively regulates the infl  amma-
tory processes. Exacerbation of experimental 
allergic asthma was observed in WSX-1–  defi  cient 
mice through aff  ecting the Th cell diff  erentia-
tion into the Th1 or Th2 linage (8). IL-27 inhibits 
CD28-mediated IL-2 production through sup-
pressor of cytokine signaling 3 (9, 10).   Studies 
in Toxoplasma gondii (11), Trypanosoma cruzi in-
fection (12), and concanavalin A–induced hep-
atitis (13) have demonstrated that WSX-1 plays 
a role in limiting the intensity and duration 
of T cell activation. IL-27 receptor–defi  cient 
mice chronically infected with Toxoplasma   gondii 
developed severe neuroinfl  ammation that was 
CD4+ T cell dependent and was associated 
with a prominent IL-17 response. In vitro, 
treatment of naive primary T cells with IL-27 
suppressed the development Th-17 cells induced 
by IL-6 and transforming growth factor-β 
(14). IL-27Rα–defi  cient mice were also hy-
persusceptible to experimental autoimmune 
encephalomyelitis and generated more IL-17–
producing Th cells (15).
It has been somewhat of an enigma why 
and how IL-27 exerts both infl  ammatory and 
anti-infl  ammatory eff  ects on T cells. A recent 
study provides an answer, which lies in the 
ability of IL-27 to stimulate both STAT1 and 
STAT3 in naive Th cells while stimulating 
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only STAT3 in activated Th cells (16). This diff  erential abil-
ity of IL-27 explains why IL-27 can activate naive Th cells 
whereas it turns inhibitory on activated Th cells. It would be 
interesting to further identify the molecular mechanism un-
derlying the diff  erential activation of STA1 and STAT3 by 
IL-27 in naive versus activated Th cells.
In addition, recent studies indicated that IL-27 has potent 
antitumor eff  ects. The antitumor activity of IL-27 against 
  colon carcinoma and neuroblastoma is mainly dependent on 
CD8+ T cell, IFN-γ, and T-bet (17–20). And the anti-B16 
melanoma eff  ect of IL-27 seems to act through suppressing 
angiogenesis (21).
Microbial infection of mammals typically triggers host 
  responses through numerous pathogen recognition receptors 
that sense pathogen-associated molecular patterns conserved 
in a large number of microorganisms. One family of such 
pathogen recognition receptors is the Toll-like receptors 
(TLRs). TLR4, in particular, is a very important receptor that 
can detect LPS derived from the cell wall of gram-negative 
bacteria. Upon recognition of LPS by TLR4 expressed on 
macrophages in conjunction with CD14, several intracellular 
signaling molecules and adaptors such as myeloid diff  erentia-
tion factor 88 (MyD88) are recruited to the ligand–receptor 
complex, triggering a downstream signaling cascade of events 
leading to the activation of a multitude of cytoplasmic   kinases 
such as mitogen-activated protein kinase and nuclear trans-
cription factors such as NF-κB and resulting in the  production 
of several proinfl  ammatory cytokines such as IL-1, TNF-α, 
IL-6, and IL-12 that drive the host response to the invading 
pathogens (22).
IFNs are widely expressed cytokines that are the frontier 
of host defense against infections and have important roles in 
immunosurveillance for malignant cells (23). IFN-γ is a type 
II interferon produced mainly by NK, NKT, CD4+ T cell, 
and CD8+ cytotoxic T cell. IFN-γ is essential for mount-
ing a cell-based immune response and promotes protection 
against the intracellular pathogens such as mycobacteria, but 
also plays a key role in the chronifi  cation of infl  ammatory 
responses such as atopic dermatitis, rheumatoid arthritis, and 
systemic lupus erythematosus (23). IFN-γ is also essential in 
immunosurveillance against malignant transformation (24). 
IFN-γ acts on a remarkable range of distinct cell popula-
tions including immune cells and nonimmune cells. Of these, 
macrophages are among the most important. IFN-γ activates 
direct microbicidal functions of macrophages and promotes 
antigen processing and presentation capacities of macro-
phages (25). The impact of IFN-γ on macrophage pheno-
type and function is achieved by a profound alteration of the 
macrophage transcriptional program in response to IFN-γ. It 
has been estimated that exposure to IFN-γ results in changes 
in expression of  25% of the mouse genome (26). Interferon 
regulatory factor (IRF)-1 is the major member of the IRF 
family of transcription factors activated by IFN-γ and is 
  essential for many IFN-γ responses.
The IRF family consists of nine mammalian transcription 
factors (IRF-1 to 9) that commonly possess a unique helix-
turn-helix DNA-binding motif (27). The fi  rst  discovered 
member of this family, IRF-1, has a remarkable functio-
nal diversity in the regulation of cellular responses in host 
  defense. IRF-1 targets diff  erent sets of genes in various cell 
types in response to diverse cellular stimuli and evokes ap-
propriate innate and adaptive immune responses (27). It has 
been fi  rmly established as a critical eff  ector molecule in IFN-γ–
mediated signaling and in the development and function 
of NK, NKT, and cytotoxic T lymphocytes (28–33). IRF-1 
also has direct anti-proliferative eff  ects, thus acting as a tumor 
suppressor and tumor susceptibility gene (34).
Given the importance of IL-27 in regulating host re-
sponse to both foreign and endogenous threats and the total 
lack of knowledge about how this cytokine is regulated, we 
undertook the present study to investigate the molecular 
mechanisms that regulate p28 subunit gene expression in 
macrophages activated by bacterial LPS and IFN-γ with a 
focus on their intracellular and nuclear eff  ectors. This study 
revealed that MyD88, NF-κB c-Rel, and IRF-1 play varying 
roles in mediating the inductive eff  ects of LPS and IFN-γ on 
p28 gene expression at the transcriptional level.
RESULTS
IL-27 p28 expression is regulated by IFN-𝗄 and LPS
We measured p28 protein and messenger RNA (mRNA) 
expression in thioglycolate-elicited mouse peritoneal macro-
phages treated with IFN-γ, LPS, or IFN-γ priming plus LPS 
in a kinetic manner. The data showed that whereas IFN-γ 
alone stimulated p28 protein secretion kinetically (Fig. 1 A) 
LPS induced  10-fold greater levels of p28 in a kinetics faster 
than that of IFN-γ stimulation (Fig. 1 B). Treatment with 
IFN-γ and LPS further increased the p28 level about fi  vefold 
compared with LPS alone (Fig. 1 B). The levels of mRNA 
expression induced by IFN-γ or LPS by and large paralleled 
those of protein production as measured by regular RT-PCR 
(Fig. 1 C) or by real-time quantitative PCR (qPCR; (Fig. 
1 D), suggesting that p28 expression is primarily regulated at 
the mRNA level.
LPS-induced p28 expression is mediated through 
MyD88–NF-𝗋B signal transduction pathway
To explore the LPS signal transduction pathway in the regu-
lation of IL-27 p28 expression, we fi  rst investigated the 
  kinetic expression pattern of p28 mRNA induced by LPS. The 
data showed LPS-induced p28 mRNA expression occurred 
as early as 1 h and reached the peak around 8 h, followed by 
a decline after 16 h (Fig. 2 A). It is well established that the 
TLR4 ligand LPS can activate downstream genes through 
both MyD88-dependent and -independent pathways. Thus 
we examined the role of MyD88 in LPS-induced p28 gene 
expression. We treated the mouse peritoneal macrophages 
elicited from WT and MyD88−/− mice with IFN-γ, LPS, or 
IFN-γ plus LPS for 24 h and measured p28 protein and 
mRNA expression by ELISA and qPCR, respectively. LPS 
induced p28 protein (Fig. 2 B) and mRNA (Fig. 2 C) expres-
sion was almost totally abolished in MyD88−/− cells, whereas JEM VOL. 204, January 22, 2007  143
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IFN-γ-induced p28 expression was partially decreased. NF-
κB plays a vital role in LPS-induced production of many 
proinfl   ammatory cytokines. In particular, c-Rel has been 
shown to be essential for IL-12 p35 gene transcription (35). 
To determine the role of c-Rel in the transcriptional induc-
tion of the p28 gene, which is homologous to p35, we treated 
the c-Rel−/− macrophages and its WT control with IFN-γ 
and LPS or IFN-γ plus LPS. The data showed that LPS-
  induced p28 protein (Fig. 2 D) and mRNA (Fig. 2 E) decreased 
by  50% compared with WT control, whereas IFN-γ–
  induced p28 expression was comparable between WT and 
c-Rel−/− cells (Fig. 2, D and E). The combined eff  ect of IFN-γ 
and LPS on p28 expression refl  ected the partial dependence 
of LPS and independence of IFN-γ on c-Rel, respectively 
(Fig. 2, D and E). These results indicate that LPS-induced 
p28 gene expression is largely dependent on the MyD88-
  mediated pathway, whereas IFN-γ–induced p28 expression 
is only partially dependent. Furthermore, c-Rel appears to be 
partially required for LPS-induced p28 expression whereas 
IFN-γ–induced p28 expression does not require c-Rel.
Expression of p28 mRNA and protein is impaired 
in IRF-1–defi  cient macrophages
Our previous study demonstrated that IFN-γ–regulated 
IL-12 p35 expression production requires IRF-1 (36). To 
determine the role of IRF-1 in IFN-γ–induced p28 gene ex-
pression, mouse peritoneal macrophages elicited from WT or 
IRF-1−/− mice were stimulated with IFN-γ, LPS, or IFN-γ 
plus LPS; cell-free culture supernatants were collected and 
subjected to ELISA for p28 protein secretion; and RNA was 
isolated and subjected to qPCR analysis. The data shows that 
both p28 protein secretion (Fig. 3 A) and mRNA expression 
(Fig. 3 B) by IRF-1−/− macrophages stimulated by IFN-γ 
were completely abrogated. Interestingly, LPS-stimulated 
p28 production (Fig. 3 A) and mRNA expression (Fig. 3 B) 
was also reduced by  85%. IFN-γ plus LPS–induced p28 
expression was also decreased in IRF-1−/− macrophages (Fig. 
3, A and B).
To gain further understanding of the mechanism of IFN-
γ–mediated induction, we analyzed the kinetic expression 
pattern of p28 mRNA in IFN-γ–treated macrophages from 
WT and IRF-1−/− mice. In WT macrophages, IFN-γ–
  induced p28 mRNA expression appeared at 3 h after IFN-γ 
treatment and reached the peak at 6 h, and then declined, 
whereas it failed to induce p28 expression in IRF-1−/− mac-
rophages at most time points except for the 12-h point (Fig. 
3 C). To confi  rm the inductive role of IRF-1 on p28 gene 
expression in primary macrophages, we performed a gene 
delivery experiment using adenovirus-expressing IRF-1 that 
we previously established (37). As shown in Fig. 3 D, the 
IRF-1 adenovirus-transduced mouse peritoneal macrophages 
displayed increased p28 mRNA expression (Fig. 3 D, top) in 
a dose-dependent manner in correlation with increased IRF-1 
Figure 1.  Expression of p28 protein and mRNA in macrophages. 
The production of IL-27 p28 was measured by ELISA from cell-free super-
natants of mouse peritoneal macrophage cultures (0.5 × 10
6 cells in 
1 ml) stimulated with IFN-γ (A) and LPS (B) or primed with IFN-γ for 16 h 
followed by LPS stimulation (B) for the indicated times in hours. Results 
shown in A and B represent the mean plus SE of three independent 
  experiments. Total RNA was isolated from these macrophages and subjected 
to both semi-quantitative (C) and quantitative real-time (D) PCR analyses 
for p28 mRNA expression. Data was normalized relative to GAPDH mRNA 
expression levels in each respective sample and further normalized to the 
sample from untreated cells, which was set as 1 (D).
Figure 2.  Role of MyD88 and NF-𝗋B in p28 expression. (A) Kinetic 
expression of p28 mRNA in LPS-treated macrophages. Total RNA was 
isolated from mouse peritoneal macrophages treated with LPS at differ-
ent time points and subjected to semi-quantitative PCR. GAPDH mRNA 
expression from the same samples was measured as a loading control. 
The production of p28 was measured by ELISA from cell-free superna-
tants of MyD88−/− (B) and c-Rel−/− (D) with their control WT macro-
phages (0.5 × 10
6 cells in 1 ml) stimulated with IFN-γ and LPS or IFN-γ 
plus LPS stimulation for 24 h. Results shown in B and D represent the 
mean plus SE of four mice per group. RNA was extracted from peritoneal 
macrophages of WT, MyD88−/− (C), and c-Rel−/− (E) mice treated with 
IFN-γ, LPS, or IFN-γ plus LPS for 6 h and subjected to qPCR analysis for 
p28 mRNA expression. Data represented pooled RNA from four mice. 
*, P < 0.05; **, P < 0.01; ***, P < 0.001.144  REGULATION OF IL-27 P28 TRANSCRIPTION BY LPS AND IFN-γ | Liu et al.
mRNA expression (Fig. 3 D, middle). The control LacZ 
adenovirus-transduced cells did not express p28 (unpublished 
data). Collectively, these results strongly demonstrate that 
IRF-1 is an essential transcription factor for p28 gene expres-
sion induced by IFN-γ, and to a lesser extent by LPS, in pri-
mary macrophages.
Reconstitution of MyD88 and IRF-1 expression 
in gene-defi  cient macrophages
To confi  rm the role of MyD88 and IRF-1 in p28 gene expres-
sion we reconstituted their expression in MyD88- and IRF-1–
defi  cient bone marrow–derived macrophages (BMDM) by 
retrovirus and lentivirus transduction, respectively. MyD88-
defi   cient BMDM were transduced with retroviral vectors 
expressing GFP or MyD88/GFP (38). As show in Fig. 4 A, 
MyD88−/− BMDM had greatly diminished response to LPS, 
which, after reconstitution, was strongly enhanced com-
pared with GFP retrovirus–transduced cells, confi  rming the 
role of MyD88 in LPS-stimulated p28 expression. In con-
trast, reconstitution of IRF-1 expression in IRF-1–defi  cient 
BMDM (Fig. 4 B) did not result in the restoration of IFN-γ 
response (Fig. 4 B, lanes 10–12), suggesting that additional, 
developmentally generated factors may be required for rescu-
ing p28 expression.
Defi  ning the p28 promoter by mapping the transcription 
initiate site
To determine whether IFN-γ–induced p28 expression is at 
the transcriptional level, we measured nascent p28 primary 
transcripts by RT-PCR using a pair of oligonucleotide prim-
ers corresponding to intron1 and exon2 of the mouse p28 
gene, respectively. As shown in Fig. 5 A, IFN-γ induced the 
p28 primary transcripts kinetically starting around 2 h (Fig. 
5 A, top). The p28 mRNA expression induced by IFN-γ 
  basically followed the primary transcript expression pattern (Fig. 
5 A, middle). These data suggests that IFN-γ–induced p28 gene 
expression is primarily exerted at the level of transcription.
To further study transcriptional regulation of the p28 
gene we decided to defi  ne its promoter region (see Materials 
and methods for details) and to map its transcription initiation 
sites (TISs). Total RNA generated from nontreated and IFN-γ–
treated mouse macrophages were used to map the TIS of the 
p28 gene by the method of 5′ RNA ligase-mediated rapid 
amplifi  cation of cDNA end (RLM-RACE). Out of the 20 
resultant clones analyzed, fi  ve sequences were identifi  ed that 
diff  ered in the sequence at the 5′ end. Thus, these diff  erent 
5′ sequences defi  ned fi  ve TISs in the p28 gene. Fig. 5 C 
shows the sequence of the p28 promoter with these fi  ve TISs 
and some putative transcription factor-biding sites indicated. 
To determine the relative importance of these fi  ve TISs, we 
performed RT-PCR using a common antisense primer and 
distinct sense primers corresponding to the unique 5′ ends 
of the fi  ve TISs. As shown in Fig. 5 D, IFN-γ treatment 
Figure 3.  Role of IRF-1 in p28 gene expression. (A) Supernatant 
from WT and IRF-1−/− peritoneal macrophage culture treated with IFN-γ 
and LPS or IFN-γ plus LPS for 24 h were analyzed for p28 production by 
ELISA. Data represents mean plus SD from four mice. (B) Total RNA was 
extracted from WT and IRF-1−/− peritoneal macrophages treated with 
IFN-γ, LPS, and IFN-γ plus LPS for 6 h and analyzed by qPCR for p28 
mRNA expression. Data was normalized relative to GAPDH mRNA expres-
sion levels of untreated WT cells in each respective sample. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001. (C) Kinetic expression of p28 mRNA in IFN-γ–
treated WT and IRF-1−/− macrophages. RNA was extracted from perito-
neal macrophages of WT and IRF-1−/− mice treated with IFN-γ at 
different times as indicated and analyzed by RT-PCR for p28 mRNA 
  expression. HPRT mRNA expression from the same samples was measured 
as a loading control. (D) WT mouse peritoneal macrophages were trans-
duced with IRF-l/adenovirus at different doses of the virus from 20 to 
160 PFU per cell for 48 h. Total RNA was extracted from the transduced 
macrophages and subjected to RT-PCR for p28 mRNA expression (top). 
The expression of IRF-1 mRNA was also measured from the same cDNA to 
verify the transduction effi  ciency (middle). GAPDH mRNA expression from 
the same samples was measured as a loading control (bottom).
Figure 4.  Reconstitution of MyD88 and IRF-1 in MyD88−/− and 
IRF-1−/− BMDM. (A) MyD88−/− BMDM were infected with retroviruses 
encoding MyD88 or GFP and treated with IFN-γ, LPS, and IFN-γ plus LPS 
for 5 h. Total RNA was extracted from the transduced BMDM and ana-
lyzed for p28 and GAPDH mRNA expression by semi-quantitative PCR 
(top) and real-time PCR (bottom). Data are one representative of two 
experiments with similar results (***, P < 0.001). (B) WT and IRF-1−/− 
BMDM were infected with lentiviruses encoding IRF-1/GFP or GFP alone 
and treated with IFN-γ and LPS for 5 h. Total RNA was extracted from the 
transduced BMDM and analyzed for p28 (top), IRF-1 (middle), and GAPDH 
(bottom) mRNA expression by semi-quantitative PCR.JEM VOL. 204, January 22, 2007  145
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  induced predominantly a transcript that originated from 
TIS(1). Thus, TIS(1) is designated +1 of the p28 promoter and 
the sequence upstream of +1 is regarded as the p28 promoter 
region. In addition, we found that LPS treatment induced 
a diff  erential TIS usage pattern identical to that of IFN-γ 
treatment (unpublished data).
Mechanism of LPS-stimulated p28 gene transcription
We were interested in elucidating the way that LPS stimu-
lates p28 gene expression. To that end we examined the LPS 
response of the initial p28 gene promoter (−940/+129) that 
we cloned. To our surprise, this promoter construct was not 
responsive to LPS in the transient transfection system in 
RAW264.7 cells (unpublished data). We then extended the 
promoter region up to −3,076, and found that this longer 
promoter became responsive to LPS while also highly re-
sponsive to IFN-γ (Fig. 6 A). Sequential 5′ deletion of this 
construct down to −739 resulted in strong loss of LPS re-
sponse, and to a lesser degree, of IFN-γ response, and of the 
synergistic response to both LPS and IFN-γ (Fig. 6 A). This 
result indicated that there are at least two LPS response ele-
ments, one residing between −3,076 and −1,222 and one 
between −1,222 and −835.
Because the transcriptionally inductive eff  ects of LPS are 
primarily mediated by NF-κB, we scanned the promoter 
region and identifi   ed four putative NF-κB binding sites 
  localized at –3,051/–3,042 (NF-κB #1), –1,230/–1,221 
(NF-κB #2), –1,189/–1,178 (NF-κB #3), and –1,146/
–1,137 (NF-κB #4). We then mutated each one of them 
and found that only mutations in the #1 element (mutant 1) 
lost a signifi  cant portion ( 40%) of its LPS response (Fig. 
6 B). Furthermore, when we cotransfected the −3,076/+129 
p28 promoter-reporter construct with an IκB-α mutant 
  expression vector, which blocks the phosphorylation of the 
endogenous IκB-α and the release of NF-κB from the NF-
κB–IκB complex resulting in suppression of the NF-κB 
nuclear translocation (39), both LPS- and IFN-γ–induced 
p28 promoter activity was abrogated (Fig. 6 C). This result 
Figure 5.  Mapping the IL-27 p28 promoter and the TISs. (A) Nascent 
p28 transcript and steady-state p28 mRNA expression. Total RNA was 
extracted from WT peritoneal macrophages treated with IFN-γ for 
different hours as indicated and reverse transcribed into cDNA using 
random primers. For p28 transcripts (top), a pair of primers fl  anking 
intron1 and exon2 were used for amplifi  cation by PCR. For steady-
state p28 (middle) and GAPDH (bottom) mRNA amplification, the 
  primers were derived from exons only. Data represents one of three 
experiments with similar results. (B) Schematic of the p28 promoter 
with the hypothetical TIS marked by a dashed arrow. The antisense 
primer (ASP) used in the RLM-RACE procedure corresponds to a seg-
ment in intron1. (C) Sequence of mouse p28 promoter that we cloned 
containing some putative transcription factor binding sites predicted by 
MatInspector and the fi  ve mapped TISs (arrows). The promoter coordi-
nates (from −940 down to +129) are relative to the most dominant 
TIS(1) (thick arrow) located at +1. (D) Relative expression levels of tran-
scripts initiated from the fi  ve different p28 TISs. Total RNA was ex-
tracted from WT peritoneal macrophages–treated IFN-γ (8 h) and 1 μg 
RNA was reverse transcribed into cDNA, which was then used to iden-
tify the p28 TIS by RLM-RACE. A common antisense primer and fi  ve 
distinct sense primers were used to amplify the differentially initiated 
p28 transcripts (mRNA) by PCR.146  REGULATION OF IL-27 P28 TRANSCRIPTION BY LPS AND IFN-γ | Liu et al.
demonstrates the crucial importance of NF-κB in the activa-
tion of p28 transcription.
To further explore the role of NF-κB #1 at 3,051/–3,042 
in the LPS response, we performed electrophoretic mobility 
shift assay (EMSA) and supershift analysis using as probe the 
−3,068/−3,026 sequence (Fig. 6 D). As shown in Fig. 6 E, 
LPS treatment induced strong nuclear binding to the probe 
(Fig. 6 E, lane 4), which was markedly shifted by the anti–
NF-κB c-Rel antibody (Fig. 6 F, lane 10) and slightly shifted 
by anti–NF-κB p65 antibody (Fig. 6 F, lane 8), demonstrat-
ing direct physical interaction of NF-κB c-Rel, and to a 
lesser extent of p65, with this NF-κB element.
Together, these results indicate that NF-κB #1 is im-
portant for p28’s LPS response, but there are additional re-
sponse elements localized between –1,222 to –835 of the 
p28 promoter.
IFN-𝗄/IRF-1 regulate p28 gene transcription through 
a specifi  c site in the p28 promoter
To elucidate the molecular basis of IFN-γ and IRF-1–medi-
ated transcriptional induction of p28, we localized the func-
tional IFN-γ/IRF-1 response element in the p28 promoter 
region. We introduced several 5′ deletion constructs of the 
p28 promoter between −739 and −40, and transfected these 
deletion constructs (linked to a luciferase reporter gene) into 
the mouse macrophage cell line RAW264.7 cells activated 
with IFN-γ. As shown in Fig. 7 A, the response to IFN-γ 
was similar among all 5′ deletion constructs except the mini-
mal construct −40, which lost substantially its ability to 
be stimulated by IFN-γ, indicating that a major IFN-γ 
  “response element” (IFN-γ–RE) in the p28 promoter was 
likely located between −140 and −40. To determine if this 
region was critical for the IRF-1 response we compared the 
ability of the −140 and −40 constructs to be activated by 
exogenously introduced IRF-1. The response to IRF-1 and 
to IFN-γ was completely lost in the −40 construct (unpub-
lished data), further indicating that IFN-γ–RE and the IRF-1–
RE are both placed in the same region of the p28 promoter 
(between −140 and −40).
To more precisely localize the IFN-γ/IRF-1–RE, a 
computer-assisted scanning was performed, and the sequence 
G  A  A  A  G  T  G  A  A  A   located at −57 to −48 matched perfectly 
Figure 6.  LPS response of p28 promoter constructs. (A) The 
−3,076/+129 and various 5′ truncation constructs of the mouse p28 
promoter-luciferase reporter were transiently transfected into RAW264.7 
cells by electroporation and the transfected cells were treated with 10 ng/ml 
IFN-γ, 1 μg/ml LPS, or IFN-γ plus LPS for 7 h. Luciferase activity from 
each construct was measured from cell lysates and normalized to the 
  activity obtained with the untreated condition as relative activities (fold 
induction). Results shown are mean plus SE of six independent experi-
ments. (B) RAW264.7 cells were transiently transfected with WT and the 
four putative NF-κB–RE mutant p28 promoter constructs. Transfected 
cells were treated with IFN-γ, LPS, or IFN-γ plus LPS for 7 h. Luciferase 
activity was measured from the cell lyses and normalized to the activity 
of medium alone as relative activities (fold induction). Data represent the 
mean ± SE from six independent experiments. *, P < 0.05; **, P < 0.001; 
***, P < 0.0001, comparing between indicated groups. (C) RAW264.7 cells 
were transiently cotransfected with the p28 (−3,076/+129) promoter and 
IκB-α mutant or its control vector at a 1:1 molar ratio. Cells were treated 
by IFN-γ, LPS, and LPS plus IFN-γ for 7 h. Luciferase activity was measured 
from cell lysates. (D) The sequence of EMSA probe with the #1 predicted 
NF-κB–RE underlined. (E) Nuclear extracts were isolated from RAW264.7 
cells after IFN-γ or LPS stimulation for 2 h. EMSA was performed with 
17 μg of nuclear extract for each sample and a double-stranded oligonucle-
otide probe containing the –3,068/−3,026 region of the mouse p28 pro-
moter. (F) A “supershift” EMSA was performed with the same probe and 
nuclear extracts from LPS-treated RAW264.7 cells. Three NF-κB–related 
antibodies and their control rabbit IgG were used (2 μg/lane).JEM VOL. 204, January 22, 2007  147
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with the consensus IRF-RE (reference 40; Fig. 7 B). To 
confi  rm the functional signifi  cance of this putative IRF-RE 
we introduced base substitutions into this site in the back-
bone of the full-length p28 promoter (−739 to +129; Fig. 
7 C). The WT and IRF-RE mutant promoter constructs 
were transiently transfected into RAW264.7 cells followed 
by stimulation with IFN-γ. The response of the mutant pro-
moter to IFN-γ was completely lost compared with the re-
sponse of the WT promoter (Fig. 7 C), so was the IRF-1 
response (Fig. 7 D), indicating that the putative IRF-RE is 
indeed critical for both IFN-γ and IRF-1 responses of the 
p28 promoter.
Thus, it appeared that NF-κB c-Rel primarily mediates 
LPS-induced p28 transcription, whereas IRF-1 principally 
drives IFN-γ–induced p28 expression. To determine if 
c-Rel and IRF-1 act synergistically on p28 transcription, we 
cotransfected these two factors into RAW2164.7 cells with 
the p28 promoter. Fig. 7 E shows that IRF-1 and c-Rel each 
alone could activate p28 gene transcription two- to threefold. 
When combined, however, they induced p28 transcription 
more than sevenfold, demonstrating a synergistic eff  ect by 
these two transcription factors.
IRF-1 binds to the IRF-RE of p28 promoter both in vitro 
and in vivo
To determine if the transcriptional activation of the p28 pro-
moter by IRF-1 was a direct event or via an indirect mecha-
nism, we performed EMSA using nuclear extracts isolated 
from RAW264.7 cells stimulated with IFN-γ or LPS. As 
shown in Fig. 8 A, there was one major IFN-γ–induced 
  nuclear DNA–binding complex formed with an oligonucle-
otide containing the WT p28 promoter’s IRF-RE (Fig. 8 A, 
lane 3, bracket). This complex was not induced by LPS (Fig. 
8 A, lane 4). The binding activity was abolished with the 
IRF-1 mutant probe (Fig. 8 A, lanes 6–8). To further con-
fi  rm the binding specifi  city, a competition EMSA was per-
formed with the cold probe and various competitors. The 
cold probe and a separate IRF-1–RE consensus probe totally 
blocked the binding (Fig. 8 B, lanes 11 and 13, respectively), 
whereas the mutant cold probe and the consensus IRF-1–RE 
mutant probes could not compete at all (Fig. 8 B, lanes 12 
and 14, respectively), nor could an unrelated probe (lane 15). 
Furthermore, a “supershift” experiment (Fig. 8 C) demon-
strated that this complex indeed contained predominantly 
IRF-1 as an anti–IRF-1 Ab was able to strongly retard its 
mobility (Fig. 8 C, lane 18) but not by antibodies directed 
toward other members of the IRF family, namely IRF-3 
and IRF-7 (Fig. 8 C, lanes 19–20). To determine if this bind-
ing activity also exists in primary macrophages we isolated 
nuclear extracts from WT and IRF-1−/− mice and performed 
EMSA with the same WT probe. IFN-γ induced a highly 
discrete binding in WT macrophages (Fig. 8 D, lane 23, ar-
row) but the inducible binding was completely absent under 
this condition in nuclear extracts isolated from IRF-1−/− 
cells (Fig. 8 D, lane 26). Interestingly, LPS treatment also 
  induced this binding activity (Fig. 8 D, lane 24) in an IRF-1–
  dependent manner (Fig. 8 D, lane 27). Note that as we re-
ported previously, in mouse peritoneal macrophages, unlike 
in RAW264.7 cells, both IFN-γ and LPS can induce IRF-1 
expression (36). These results demonstrate that IRF-1 specif-
ically and directly interacts with the IRF-RE in the p28 pro-
moter in vitro.
To determine if the interaction between IRF-1 and the 
p28 promoter occurs in vivo, chromatin immunoprecipita-
tion (ChIP) assay was performed in mouse peritoneal macro-
phages. Fig. 8 E illustrates the region of the p28 promoter 
containing the IRF-RE that was examined in the ChIP assay. 
Fig. 8 F demonstrates that both IFN-γ and LPS induced 
strong binding of IRF-1 to this region of the p28 promoter 
detected specifi  cally by the anti–IRF-1 antibody (Fig. 8 F, 
lanes 3–4) but not by the control IgG (Fig. 8 F, lanes 6–7).
Figure 7.  IFN-𝗄–activated p28 promoter through IRF-RE. (A) The 
−739/+129 and various 5′ truncation constructs of the mouse p28 pro-
moter-luciferase reporter were transiently transfected into RAW264.7 
cells by electroporation, and the transfected cells were treated with IFN-γ 
for 7 h. IFN-γ–induced luciferase activity from each construct was mea-
sured from cell lysates and normalized to the activity obtained with the 
untreated condition as relative activities (fold induction). Results shown 
are mean plus SE of fi  ve independent experiments. (B) Sequence of the 
WT mouse p28 promoter region containing the IRF-RE, and that of the 
IRF-RE mutant with specifi  c base substitutions underlined. (C) RAW264.7 
cells were transiently transfected with WT or the IRF-RE mutant p28 pro-
moter. The transfected cells were treated with 10 ng/ml IFN-γ for 7 h. 
Luciferase activity was measured from the cell lyses. Data represent the 
mean ± SE from six independent experiments. *, P < 0.05, comparing 
IFN-γ–treated and untreated conditions. (D) RAW264.7 cells were tran-
siently transfected with WT or the IRF-RE mutant p28 promoter together 
with the IRF-1 expression vector or its control vector at a 1:1 molar ratio 
of reporter/effector. Cells were not further stimulated before luciferase 
activity measurement. Data represent the mean ± SE from six indepen-
dent experiments. (E) RAW264.7 cells were transiently transfected with 
WT p28 promoter together with the IRF-1 and c-Rel expression vectors or 
their respective control vectors pACT-C and pMFG (reference 36). 
Cells were not further stimulated before luciferase activity measurement. 
Data represent the mean ± SE from three independent experiments. 
***, P < 0.001, comparing IRF-1–effected and control vector–
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D  I  S  C  U  S  S  I  O  N 
IL-27 is the latest addition to the IL-12 family of heterodi-
meric cytokines composed also of IL-12 and IL-23. Members 
of this family share ligand and receptor subunits and play 
somewhat overlapping roles in innate and adaptive immune 
responses. These three cytokines are not entirely redundant, 
as they may preferentially activate naive or memory T cells, 
induce discrete T cell cytokine profi  les, contribute to distinct 
stages of host immune responses to infectious agents, and dif-
ferentially promote autoimmunity (41). Further elucidation 
of the unique functions of the IL-12 family members may 
lead to better understanding of T and NK cell immunobio-
logy and improved immunodiagnostics and therapies. The 
physiological importance of IL- 27 compelled us to initiate 
this study to investigate the molecular mechanisms involved 
in the regulation of the production of its constituent p28 
gene by macrophages.
In this study, we made several fi  ndings that were partly 
expected and partly surprising. First, unlike its closest rela-
tive IL-12 p35, which is not secreted alone by activated 
macrophages, IFN-γ alone can stimulate p28 synthesis and 
secretion (Fig. 1 A). However, p28, similarly to p35 or p19, 
is not effi   ciently secreted by the cells if the second chain 
EBI3 (or p40 for the other two cytokines) is not expressed. 
Although it has been reported that mouse p28 may be se-
creted at low levels by transfected cells, this is supposed to be 
very ineffi   cient. Thus, it is possible that all or most of p28 
that is present is associated with EBI3. The situation is com-
plicated by the fact that, unlike IL-12 or IL-23, the IL-27 
heterodimer is not covalently linked. Also, although the 
manufacturer of the p28 ELISA system indicates a cross-
  reactivity of 7% with IL-27, the antigen used in immunization 
was a hyperkine single chain molecule that may react diff  er-
ently with the antibody than the native protein. Thus, it is 
possible that the physiological heterodimer is recognized in 
the ELISA assay.
Again, like p35, IFN-γ and LPS have a synergism in the 
induction of p28 expression (Fig. 1 B). LPS stimulated much 
greater levels of p28 production than IFN-γ with a faster 
  kinetics than IFN-γ (Fig. 1 B). This suggests that IFN-γ–
  induced IL-27 production may be a secondary event to micro-
bial infection. Furthermore, LPS-induced p28 production, 
like IL-12 (42), is totally dependent on MyD88 (Fig. 2, B 
and C). Unlike p35, NF-κB c-Rel is partially dispensable for 
p28 production (Fig. 2, D and E). It would be interesting and 
necessary to examine the role of other common NF-κB 
components (p50 and p65) in this regard.
The reconstitution of IRF-1 expression in IRF-1–defi  -
cient BMDM, surprisingly, did not lead to restoration of 
IFN-γ–stimulated p28 expression (Fig. 4 B) unlike MyD88 
reconstitution, which did fully restore LPS-induced p28 ex-
pression (Fig. 4 A), considering the transduction effi   ciency. 
Germline gene knockouts could potentially aff  ect other genes 
developmentally, temporally, and spacially rather than the 
one targeted. In other words, we speculate that it is possible 
when a gene is eliminated in the germline, other genes that 
are dependent on this gene can be aff  ected very early. Thus, 
reconstitution in a late stage of the life cycle can’t rescue all 
the functions and activities of the targeted gene throughout 
the entire life of the animal. IRF-1 and p28 may fall into this 
kind of relationship.
Our previous study demonstrated that IRF-1 is required 
for IL-12 p35 gene transcription in macrophages in response 
to IFN-γ and partially to LPS (37). The present study 
  revealed similar requirements of IRF-1 for IFN-γ– and 
LPS-stimulated p28 gene expression (Fig. 3). That introduc-
ing IRF-1 expression into primary macrophages could in-
duce p28 expression (Fig. 3 D) indicates that IRF-1 plays 
an important role in the transcriptional activation of p28. 
Figure 8.  IRF-1 binds to p28 promoter in vitro and in vivo. 
(A) Nuclear extracts were isolated from RAW264.7 cells after IFN-γ or LPS 
stimulation for 4 h. EMSA was performed with 10 μg of nuclear extract 
for each sample and a double-stranded oligonucleotide probe containing 
the −70/−34 region of the WT or mutant mouse p28 promoter 
  (sequence given with the critical IRF-RE and the mutations underlined). 
(B) Competitive EMSA was performed with the −70/−34 probe and vari-
ous competitors as indicated. (C) A supershift EMSA was performed with 
the −70/−34 probe and nuclear extracts from ether IFN-γ–treated 
RAW264.7 cells. Three IRF-related antibodies and their control rabbit IgG 
were used (2 μg/lane). (D) Nuclear extracts were isolated from thioglyco-
late-elicited primary mouse peritoneal macrophages from WT and 
IRF-1−/− mice after IFN-γ or LPS stimulation for 4 h. EMSA was performed 
with 10 μg of nuclear extract for each sample and a double-stranded 
oligonucleotide probe containing the −70/−34 region of the WT mouse 
p28 promoter. (E) Sequence of mouse p28 promoter containing IRF-RE. 
The sequences of the pair of PCR primers used to perform ChIP are under-
lined as well as the IRF-RE. (F) ChIP analysis was performed in WT mouse 
peritoneal macrophages. The amplifi  ed mouse genomic fragment derived 
from the endogenous p28 promoter encompassing the IRF-RE is indi-
cated. The control antibody was an isotype-matched IgG. Input DNAs 
were used as controls.JEM VOL. 204, January 22, 2007  149
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This notion is strongly buttressed with data showing that 
both IFN-γ– and IRF-1–stimulated p28 transcription maps 
to the same IRF-RE located at −57/−48 of the p28 pro-
moter (Fig. 7, C and D) and that IFN-γ–induced endo-
genous IRF-1 binds to the same site both in vitro and 
in vivo (Fig. 8).
After the establishment that p28 expression was regulated 
primarily at the level of transcription (Fig. 5 A), we cloned 
the mouse p28 gene promoter and identifi  ed fi  ve TISs, of 
which one is predominantly used in macrophages (Fig. 5 D). 
It is possible that the other four TISs are used in diff  erent cell 
types or under diff  erent stimulatory conditions according to 
the physiological cues and needs. Our initial p28 promoter 
construct containing the region between −940 and +129 
was rather robust in terms of its response to IFN-γ stimula-
tion, but highly unresponsive to LPS stimulation. In the pro-
cess of determining p28’s TIS, we identifi  ed a transcriptional 
“pausing” site between +129 and +289, meaning that there 
is a constitutive level of transcription independent of stimula-
tion that stops in this region unless the cell receives stimula-
tion by LPS or IFN-γ. This observation prompted us to 
extend the −739/+129 p28 promoter construct further 
downstream to include the region between +129 and +289 
with the rationale that this additional region may contain an 
LPS-response element. However, the more extended con-
struct remained unresponsive to LPS (unpublished data). We 
then reasoned that the LPS response element may be located 
upstream of −940. Indeed, extending the promoter further 
upstream revealed at least two critical regions for LPS re-
sponse, one located at −3,051/−3,042 that interacts strongly 
with LPS-induced c-Rel (Fig. 6), and the other located be-
tween −1,222 and −940 that remains to be fully character-
ized. In addition, we demonstrated that IRF-1 and c-Rel can 
transactivate the p28 promoter in a synergistic manner (Fig. 
7 E), representing the likely combined eff  ects of IFN-γ and 
LPS on p28 transcription.
In summary, we report the fi  rst study of the molecular 
regulatory mechanisms involved in the transcription of IL-27 
p28 gene in IFN-γ– and LPS-activated macrophages. We 
identifi  ed the TIS within the p28 gene promoter and deter-
mined the relative roles that MyD88, c-Rel, and IRF-1 
play in the regulation of p28 gene expression, and the mole-
cular mechanisms whereby IRF-1 and NF-κB contribute 
critically to IFN-γ and LPS-induced p28 expression. This 
study will serve to lay an important foundation for further 
exploration of IL-27’s multifaceted immunobiology in health 
and diseases.
MATERIALS AND METHODS
Mice. Female IRF-1−/− mice and their control, C57BL/6J mice ( 6–8 wk 
old), were obtained from The Jackson Laboratories. c-Rel−/− mice were 
supplied by H.-C. Liou (Weill Medical College of Cornell University, 
New York, NY). A. Ding and E. Falck-Pedersen (Weill Medical College 
of  Cornell University, New York, NY) provided the MyD88−/− mice 
originated from S. Akira (Osaka University, Osaka, Japan). All mice were 
housed in cages with fi  lter tops in a laminar fl  ow hood and fed food and 
acid water ad libitum at Weill Medical college of Cornell University Animal 
Facilities in accordance with the principles of Animal Care of the National 
Institutes of Health. These studies were reviewed and approved by the 
  institutional Animal Care and Use Committee of Weill Medical College 
of Cornell University.
Cells. The mouse macrophage cell line RAW264.7 (RAW cells hereafter) 
was obtained from American Type Culture Collection and maintained in 
RPMI 1640 supplemented with 2 mM glutamine, 100 U/ml of penicillin 
and streptomycin, and 10% FBS (Hyclone; endotoxin <1 ng/ml). Mouse 
peritoneal exudate macrophages were obtained by lavage 4 d after injection 
of sterile 3% thioglycolate broth (1 ml i.p.). Cells were washed and resus-
pended in RPMI containing 10% FCS and standard supplements. Macro-
phages were plated in 24-well tissue culture dishes (0.5 × 106 cells/well). 
After 2-h incubation to allow for adherence of macrophages, monolayers 
were washed three times to remove nonadherent cells and incubated with 
RPMI containing 10% FCS and standard supplements. The next day, 
10 ng/ml IFN-γ and 1 μg/ml LPS were added at diff  erent time points.
Mouse BMDM were generated from bone marrow stem cells obtained 
from the femurs of the mice. After lysis of the red blood cells, 2 × 106 of 
bone marrow stem cells were inoculated in 60-mm Petri dishes with com-
plete DMEM culture medium containing 10% FCS, 20% l-medium, and 
standard supplements. After 7-d culture, the fully diff  erentiated and matured 
BMDM were treated with 10 ng/ml IFN-γ and 1 μg/ml LPS for 5 h for 
RNA extraction.
Plasmids. Mouse p28 promoter that extended from –3076 to +129 was 
amplifi  ed by PCR with genomic DNA extracted from the spleen of WT 
C57BL/6 mice (5′ primer: T  T  G  G  C  A  C  T  G  A  C  A  T  C  A  C  G  G  A  A  C  C  T  A  ; 3′ 
primer: C  C  T  G  T  C  A  A  A  C  T  T  T  C  C  C  A  A  C  C  ). The PCR product was cloned 
into the PCR2.1 cloning vector (Invitrogen). After sequence verifi  cation the 
insert in PCR2.1 was excised with XhoI and HindIII and cloned into pGL2-
basic luciferase vector (Promega). The IRF-1 and NF-κB mutant p28 pro-
moter constructs were generated by site-directed mutagenesis according to 
manufacturer’s protocol (Stratagene). Expression vector pAct-1 (IRF-1) and 
control pAct-C were provided by T. Taniguchi (University of Tokyo, 
  Tokyo, Japan). C-Rel and IκB-α mutant vectors were previously described 
(36). MyD88/GFP and control pMSCV-GFP retrovirus vectors were pro-
vided by A. Ding. For cloning IRF-1 lentivirus vector, the full length of 
mouse IRF-1 cDNA was released by EcoRI from the IRF-1/adenovirus 
vector (36) and blunted by Klenow. Dephosphorylated blunt-end IRF-1 
cDNA was cloned into MA-1 vector, which was blunted by Klenow after 
cut by SmaI and SalI and then by sequence verifi  cation. The empty MA-1 
lentivirus vector and its package vectors (VSV-G, pMDLg/p RRE, and 
pRSV-REV plasmids) were provided by S. Rivella (Weill Medical College 
of Cornell University, New York, NY). All plasmid DNA for transfection 
were prepared with Endo-free Maxi-Prep kits (QIAGEN).
Reagents. Antibodies for IRFs and NF-κB components used in this study 
were purchased from Santa Cruz Biotechnology, Inc. Recombinant mouse 
IFN-γ was purchased from Genzyme. LPS from Escherichia coli 0217:B8 was 
purchased from Sigma-Aldrich.
Retroviral and lentiviral packaging and transduction. GP2-293 pack-
aging cells (CLONTECH Laboratories, Inc.) at  50–70% confl  uency in 
100-mm culture plates were transfected with 5 μg each of plasmids encod-
ing a protein (pVSV-G; CLONTECH Laboratories, Inc.) and MyD88, 
  using FuGENE 6 (Roche). 2 d after transfection, supernatants were cleared 
by centrifugation at 1,000 g for 10 min and were pelleted at 50,000 g for 
90  min. Pelleted viruses were resuspended overnight at 4°C in 100 μl 
of 50 mM Tris-HCl, pH 7.8, 130 mM NaCl, and 1 mM EDTA. Bone 
  marrow cells were infected with retroviral particles on day 2 and again on 
day 4 during their maturation in the presence of 20% l-cell medium. On 
day 7, mature macrophages were incubated for 5 h with fresh medium 
plus IFN-γ, LPS, and IFN-γ plus LPS after which RNA was isolated for 
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For lentivirus generation, HEK293TN cells (System Biosciences) at 
50% confl  uency were transfected with 3 μg ENV plasmid (VSV-G), 5 μg 
pMDLg/p RRE plasmid, 2.5 μg pRSV-REV plasmid, and 10 μg IRF-1/
MA-1 expression plasmid or 10 μg of control GFP plasmid using FuGENE 6. 
Subsequent steps were identical to those for the preparation of the retrovirus 
described in the previous paragraph.
RT-PCR. RT-PCR reactions were performed under standard condi-
tions (39). The following primers were used for PCR amplifi  cation of 
the mouse p28 cDNA: sense, C  T  C  T  G  C  T  T  C  C  T  C  G  C  T  A  C  C  A  C  ; anti-
sense, G  G  G  G  C  A  G  C  T  T  C  T  T  T  T  C  T  T  C  T  ; mouse IRF-1 sense, C  A  G  A  G  G-
A  A  A  G  A  G  A  G  A  A  A  G  T  C  C  ; antisense, C  A  C  A  C  G  G  T  G  A  C  A  G  T  G  C  T  G  G  ; 
mouse HPRT sense, G  T  T  G  G  A  T  A  C  A  G  G  C  C  A  G  A  C  T  T  T  G  T  T  G  ; antisense, 
G  A  G  G  G  T  A  G  G  C  T  G  G  C  C  T  A  T  G  G  C  T  .
qPCR. To determine the level of mRNA expression by qPCR, we used a 
modifi  ed protocol from Rajeevan et al. (43). In brief, cDNA converted from 
1 μg of total RNA was diluted in a several concentrations. Diluted cDNA 
was mixed with a pair of primers (10 μM) derived from mouse p28 or 
GAPDH cDNA sequences and SYBR green PCR master mix (Applied Bio-
systems) in a 15-μl volume. PCR cycling was as follows: 2 min at 50°C, 
10 min at 95°C for 1 cycle followed by 15 s at 95°C for 40 cycles, and 1 min at 
60°C. The PCR primers used for mouse GAPDH were forward, A  A  C  T  T  T-
G  G  C  A  T  T  G  T  G  G  A  A  G  G  , and reverse, A  C  A  C  A  T  T  G  G  G  G  G  T  A  G  G  A  A  C  A  .
Enzyme-linked immunosorbent assays. Supernatants from mouse peri-
toneal macrophage cultures were harvested at 6, 12, and 24 h after IFN-γ 
and LPS stimulation and stored at −70°C. Mouse IL-27 p28 was detected 
using the Quantikine ELISA kits (R&D Systems) according to the manufac-
turer’s instructions. Concentrations were calculated by regression analysis of 
a standard curve.
Defi   ning the mouse p28 gene promoter region. We fi  rst used the 
mouse p28 mRNA sequence (available from GenBank/EMBL/DDBJ under 
accession no. AY099297) to blast the public database and identifi  ed a mouse 
chromosome 7 genomic contig containing the p28 gene (available from 
GenBank/EMBL/DDBJ under accession no. NT_039433.5). Based on the 
genomic sequence, the precise TIS was defi  ned by RLM-RACE (see the 
following section). Thus, the promoter region of p28 gene is defi  ned as 
  sequences upstream of the TIS.
RLM-RACE. RLM-RACE was used to determine the TISs of mouse p28 
gene using an assay kit (Invitrogen). In brief, 5 μg of total RNA treated with 
IFN-γ or LPS at diff  erent time points were dephosphorylated with calf 
  intestinal phosphatase. The full-length capped mRNA was then treated with 
tobacco acid pyrophosphatase to remove the 5′ 7-methyl guanine cap of 
  intact, mature mRNA molecules. RNA molecules that had 5′ phosphate 
groups, including degraded or unprocessed mRNAs lacking a 5′ cap, struc-
tural RNAs, and traces of contaminating genomic DNA, were dephosphor-
ylated by calf intestinal phosphatase treatment and were therefore not ligated 
to the adaptor primer sequence. The decapped mRNA was ligated with a 
44-base GeneRacer RNA oligo (5′-C  G  A  C  U  G  G  A  G  C  A  C  G  A  G  G  A  C  A  C  U-
G  A  C  A  U  G  G  A  C  U  G  A  A  G  G  A  G  U  A  G  A  A  A  -3′) using T4 RNA ligase. The li-
gated mRNA was reverse transcribed using SuperScript III RT and oligo dT 
primer to create RACE-ready fi  rst-strand cDNA with known priming sites 
at the 5′ ends. The 5′ ends of the p28 gene transcript were amplifi  ed using 
two nested sense primers corresponding to the RNA oligo sequence and 
two nested antisense primers specifi  c to p28 mRNA (outer, 5′-A  G  C  A  T  G  G-
C  A  G  G  G  A  A  G  G  G  C  C  G  A  A  G  T  G  T  -3′; inner, 5′-T  C  C  C  T  G  C  G  C  A  G  C  T  C  T-
T  G  A  A  G  G  C  T  C  A  -3′). PCR conditions were at 94°C for 2 min for 1 cycle, 
94°C for 30 s, 66°C for 30 s, 68°C for 1 min for 20 cycles, and 68°C for 
10 min. The PCR product was size fractionated by 1.2% agarose gel–
  electro  phoresis. Two bands of  350 and 125 bp were excised from the 
gel and purifi  ed. The purifi  ed PCR products were cloned and sequenced. 
The transcription start sites of the p28 gene were defi  ned by aligning the 
5′ RLM-RACE sequences with the p28 gene sequence.
Primary transcript measurement. To determine the primary transcrip-
tion rate of p28 gene induced by IFN-γ, cDNA were synthesized with ran-
dom primers using 1 μg of total RNA generated from IFN-γ–treated mouse 
macrophages. The region fl   anking intron1 and exon2 was amplifi  ed  by 
PCR. The primers for primary transcript are as follows: p28 intron1 (sense), 
A  G  T  T  A  T  G  T  A  G  G  C  T  G  G  G  C  A  C  T  G  G  A  A  ; p28 exon2 (antisense): A C  G  A  C-
T  G  C  A  A  G  A  T  T  G  G  A  G  C  A  C  T  T  G  . PCR amply conditions were 94°C for 
4 min for 1 cycle, 94°C for 15 s, 60°C for 30 s, 72°C for 30 s for 30 cycles, 
and 72°C for 7 min. PCR products were run on 1.2% agarose gel.
Nuclear extract preparation. Nuclear extracts for Western blot and 
EMSA were prepared according to the methods of Schreiber et al. (44).
Adenoviral vectors and their propagation. The construction and prop-
agation of LacZ- and IRF-1–expressing adenovirus were described else-
where (36, 37).
Transfection assay. Transient transfections were performed by electropora-
tion as previously described (45).
EMSA. EMSA and supershifts were performed as described previously (46).
ChIP assay. The ChIP procedure was performed using an assay kit follow-
ing the manufacturer’s instructions (Upstate Biotechnology) and as pre-
viously described (36). The input and immunoprecipitated DNA were 
amplifi  ed by PCR using primers encompassing the IRF-1–RE in the 
mouse p28 promoter (5′ primer, C  C  C  T  C  T  G  G  G  A  A  G  G  G  A  A  A  T  T  A  C  G  T  T  ; 
3′ primer, C  C  T  G  T  C  A  A  A  C  T  T  T  C  C  C  A  A  C  C  ). The samples were amplifi  ed 
for 30 cycles and analyzed by electrophoresis on a 1.2% agarose gel.
Statistical analysis. Student t test was performed wherever applicable. 
Standard deviation of the mean is shown unless otherwise indicated. 
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
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